Metabolomics Workbench : NIH Data Repository

Log in / Register

Clustering data with hclust algorithm for Metabolomic and lipidomic profiles in response to exogenous insulin and GLP-1 infusions during prolonged fasting (Study ST000107)

LCMS Positive ion mode (Analysis AN000177)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14	F15
2-Arachidonoyl Glycerol	ME659981	0.89	1.34	1.14	1.05	1.78	0.81	0.41	0.42	0.36	0.30	2.73	1.27	4.17	1.46	0.74
2-Linoleoyl Glycerol	ME659979	0.95	0.86	0.65	1.47	1.19	2.29	0.77	0.88	0.87	0.61	0.59	0.49	0.49	0.61	1.93
2-Oleoyl Glycerol	ME659977	0.69	0.64	0.58	1.19	1.06	2.26	0.67	0.80	0.73	0.57	0.76	0.86	0.81	0.89	2.78
1-Arachidonoyl Glycerol	ME659980	1.24	0.85	1.52	1.36	1.53	1.19	0.65	0.87	0.61	0.62	1.56	0.88	1.89	0.93	0.87
Docosahexaenoyl Ethanolamide	ME659990	1.00	0.99	1.00	0.91	1.35	0.97	0.72	0.78	0.75	0.71	1.36	1.56	1.73	1.65	1.10
1-Linoleoyl Glycerol	ME659978	0.62	0.29	0.56	0.90	0.59	1.47	1.19	1.63	1.42	0.83	0.38	0.55	0.44	0.74	0.85
PGF2a Ethanolamide	ME659991	0.85	0.67	0.66	0.62	0.46	1.34	1.38	1.22	1.07	1.07	0.69	0.58	0.75	0.87	0.93
1-Oleoyl Glycerol	ME659976	0.85	0.33	0.99	1.51	0.88	1.67	1.10	1.11	0.68	0.80	0.71	0.72	0.81	0.85	1.57
Docosatetraenoyl Ethanolamide	ME659989	1.00	0.51	1.00	0.70	0.44	1.56	0.95	0.85	0.70	0.87	1.19	1.42	0.97	1.07	1.94
Stearoyl Ethanolamide	ME659983	0.59	0.49	0.76	0.75	0.98	1.48	0.99	1.00	0.85	1.07	1.07	0.98	0.92	1.43	1.10
Linoleoyl Ethanolamide	ME659985	0.94	0.86	0.95	0.72	0.77	1.17	0.95	0.98	0.88	0.88	1.20	1.30	1.37	1.14	1.07
Palmitoyl Ethanolamide	ME659982	0.96	0.95	1.01	0.91	0.80	1.20	0.85	1.05	0.97	1.05	1.03	0.95	1.01	1.16	0.87
a-Linolenoyl Ethanolamide	ME659986	1.32	1.11	1.11	0.75	0.83	1.56	0.87	0.82	0.88	0.78	1.26	0.94	1.29	0.62	0.94
Arachidonoyl Ethanolamide	ME659988	1.31	1.01	1.25	0.83	0.44	1.31	1.05	1.01	1.00	0.93	0.75	0.81	0.81	0.67	1.36
Dihomo-g-Linolenoyl Ethanolamide	ME659987	1.05	1.01	1.54	1.11	0.77	1.29	0.88	0.79	0.83	0.82	1.26	1.08	0.85	0.89	1.43
Oleoyl Ethanolamide	ME659984	1.12	0.89	1.20	0.95	0.63	1.32	0.94	0.94	0.77	0.95	0.99	1.06	1.00	0.85	1.50

Factors:

F1	Treatment:Early ITT Infusion Study \| Timepoint:0 mins
F2	Treatment:Early ITT Infusion Study \| Timepoint:10 mins
F3	Treatment:Early ITT Infusion Study \| Timepoint:120 mins
F4	Treatment:Early ITT Infusion Study \| Timepoint:30 mins
F5	Treatment:Early ITT Infusion Study \| Timepoint:60 mins
F6	Treatment:GLP1/Late GTT \| Timepoint:0 mins
F7	Treatment:GLP1/Late GTT \| Timepoint:10 mins
F8	Treatment:GLP1/Late GTT \| Timepoint:120 mins
F9	Treatment:GLP1/Late GTT \| Timepoint:30 mins
F10	Treatment:GLP1/Late GTT \| Timepoint:60 mins
F11	Treatment:Late ITT Infusion Study \| Timepoint:0 mins
F12	Treatment:Late ITT Infusion Study \| Timepoint:10 mins
F13	Treatment:Late ITT Infusion Study \| Timepoint:120 mins
F14	Treatment:Late ITT Infusion Study \| Timepoint:30 mins
F15	Treatment:Late ITT Infusion Study \| Timepoint:60 mins

Data matrix